Keyphrases
Syngeneic
100%
P-glycoprotein (P-gp)
100%
P-glycoprotein Inhibitor
100%
Doxorubicin
71%
Cyclosporine
57%
Anticancer Drugs
42%
Tumor Growth
28%
Multidrug Resistance
28%
Growth Kinetics
14%
Overexpression
14%
Weight Loss
14%
Western Blot Analysis
14%
Drug Efflux
14%
Efflux Proteins
14%
Tumor Cells
14%
Significant Loss
14%
Reduced Sensitivity
14%
Clinical Utility
14%
Tumorigenicity
14%
Improved Prediction
14%
Tumor Inhibition
14%
Multidrug Resistance Phenotype
14%
Accumulation Assay
14%
Cytotoxic Drugs
14%
Intracellular Accumulation
14%
In Vivo System
14%
Murine Cells
14%
Cancer Chemotherapy
14%
Immunology and Microbiology
Syngenic
100%
P-Glycoprotein
100%
Multidrug Resistance
77%
Cell Line
33%
Ciclosporin
33%
Western Blot
11%
Mouse
11%
Tumor Cell
11%
Cytotoxicity
11%
Body Weight
11%